Citadel Advisors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $50M | Sell |
|
|||||
|
2023
Q3 | $32.1M | Buy |
|
|||||
|
2023
Q2 | $20.5M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $5.54M | Sell |
|
|||||
|
2022
Q3 | $18.9M | Buy |
|
|||||
|
2022
Q2 | $2.48M | Buy |
|
|||||
|
2022
Q1 | $2.12M | Buy |
|
|||||
|
2021
Q4 | $966K | Sell |
|
|||||
|
2021
Q3 | $1.4M | Buy |
|
|||||
|
2021
Q2 | $207K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $2.67M | Buy |
|
|||||
|
2020
Q3 | $696K | Buy |
|
|||||
|
2020
Q2 | $826K | Sell |
|
|||||
|
2020
Q1 | $6.03M | Buy |
|
|||||
|
2019
Q4 | $351K | Sell |
|
|||||
|
2019
Q3 | $1.28M | Sell |
|
|||||
|
2019
Q2 | $2.52M | Buy |
|